High materiality9/10
Mirum Pharmaceuticals (MIRM) PT Raised to $146 at Citizens After ENDO Data Reveal
Why it may matterVerify against the original reporting
Analyst target update; bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Analyst target update by CLSA; target raised to $146; posted price 99.35; priceChangeSinceSignal 1.67.
- CLSA raises MIRM target to $146; price 99.35.
Key facts
- 01
Target: $146
- 02
Posted price: $99.35
- 03
Analyst firm: CLSA
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.